scholarly journals Usual Ductal Breast Hyperplasia

2020 ◽  
Author(s):  
Keyword(s):  
Breast Hyperplasia

Benign Diffuse Breast Hyperplasia during Pregnancy

2006 ◽  
Vol 355 (26) ◽  
pp. 2771-2771 ◽  
Author(s):  
Shikha Pasrija ◽  
Nayantara Sharma
Keyword(s):  
Breast Hyperplasia

Condition of the reproductive system of the women with benign breast hyperplasia

2000 ◽  
Vol 70 ◽  
pp. A132-A132
Author(s):  
A.S. Ganarov ◽  
I.V. Burets ◽  
A.I. Voobuev ◽  
A.G. Melikian ◽  
P.A. Basanov
Keyword(s):  
Reproductive System ◽  
Breast Hyperplasia

Menstrual cycle and hormonal status of the women with benign breast hyperplasia

2000 ◽  
Vol 70 ◽  
pp. A131-A131
Author(s):  
I.V. Burets ◽  
A.S. Gasparov ◽  
A.I. Volobuev ◽  
P.A. Basanov ◽  
O.E. Barabanova
Keyword(s):  
Menstrual Cycle ◽  
Hormonal Status ◽  
Breast Hyperplasia

scholarly journals 2D-DIGE Proteomic Analysis of Changes in Estrogen/Progesterone-Induced Rat Breast Hyperplasia upon Treatment with the Mongolian Remedy RuXian-I

Molecules ◽  
2011 ◽  
Vol 16 (4) ◽  
pp. 3048-3065 ◽  
Author(s):  
Zhong-Chao Wang ◽  
Du E ◽  
De-Ligen Batu ◽  
Ya-Latu Saixi ◽  
Bin Zhang ◽  
...  
Keyword(s):  
Proteomic Analysis ◽  
2D Dige ◽  
Breast Hyperplasia

scholarly journals Ibuprofen Induces Reduction of the Proliferation-Seeking Radiotracer 99m Tc-(V)DMSA Uptake in Severe Epithelial Breast Hyperplasia without Atypia

2010 ◽  
Vol 9 (5) ◽  
pp. 7290.2010.00028
Author(s):  
Vassilios Papantoniou ◽  
Angeliki Tsaroucha ◽  
Pipitsa Valsamaki ◽  
Spyridon Tsiouris ◽  
Evangelia Sotiropoulou ◽  
...  
Keyword(s):  
Breast Hyperplasia

scholarly journals Gene expression signature of atypical breast hyperplasia and regulation by SFRP1

2019 ◽  
Vol 21 (1) ◽  
Author(s):  
Kelly J. Gregory ◽  
Amy L. Roberts ◽  
Erin M. Conlon ◽  
Jacob A. Mayfield ◽  
Mary J. Hagen ◽  
...  
Keyword(s):  
Gene Expression ◽  
Gene Expression Signature ◽  
Expression Signature ◽  
Breast Hyperplasia

scholarly journals Molecular fingerprint of precancerous lesions in breast atypical hyperplasia

2020 ◽  
Vol 48 (6) ◽  
pp. 030006052093161
Author(s):  
Chao Zheng ◽  
Hong Ying Jia ◽  
Li Yuan Liu ◽  
Qi Wang ◽  
Hong Chuan Jiang ◽  
...  
Keyword(s):  
Raman Spectroscopy ◽  
Precancerous Lesions ◽  
Atypical Hyperplasia ◽  
Control Group ◽  
Molecular Fingerprinting ◽  
Related Factors ◽  
Molecular Fingerprint ◽  
Non Invasive ◽  
Acid Protein ◽  
Breast Hyperplasia

Objective To identify atypical hyperplasia (AH) of the breast by shell-isolated nanoparticle-enhanced Raman spectroscopy (SHINERS), and to explore the molecular fingerprinting characteristics of breast AH. Methods Breast hyperplasia was studied in 11 hospitals across China from January 2015 to December 2016. All patients completed questionnaires on women’s health. The differences between patients with and without breast AH were compared. AH breast lesions were detected by Raman spectroscopy followed by the SHINERS technique. Results There were no significant differences in clinical features and risk-related factors between patients with breast AH (n = 37) and the control group (n = 2576). Fifteen cases of breast AH lesions were detected by Raman spectroscopy. The main different Raman peaks in patients with AH appeared at 880, 1001, 1086, 1156, 1260, and 1610 cm−1, attributed to the different vibrational modes of nucleic acids, β-carotene, and proteins. Shell-isolated nanoparticles had different enhancement effects on the nucleic acid, protein, and lipid components in AH. Conclusion Raman spectroscopy can detect characteristic molecular changes in breast AH lesions, and may thus be useful for the non-invasive early diagnosis and for investigating the mechanism of tumorigenesis in patients with breast AH.

Sign in / Sign up

Export Citation Format

Share Document